Chronic infections can upset the body's immune balance, causing persistent inflammation. Unlike traditional antimicrobial treatments, which can harm the body's natural ecosystem without fully resolving the issue, Low Dose Immunotherapy (LDI) fine-tunes your immune response. This prevents overreactions to these invaders without the potential risks of extended medication use.
Peptide Immunotherapy is a pioneering medical strategy that employs specific peptides to finely tune the immune system's responses. These peptides interact with immune cells to promote balanced responses and enhance the body's natural defense mechanisms. We offer specialized peptide therapy that focuses on the targeted administration of immunomodulating and immunosupportive peptides. This approach allows us to reduce inflammation, decrease mast cell activation, and support the production of immune cells (NK cells, dendritic cells).
Research highlights the importance of peptide immunotherapy in cancer management, biotoxin illness, CIRS, and autoimmune diseases, identifying the positive impact of peptides on immune modulation. Studies have shown that certain anti-inflammatory peptides can enhance inhibitory activity against lipopolysaccharide-induced inflammation.
Chronic Fatigue
Autoimmune Disorders
Viral and Bacterial Infections
Allergies and Sensitivities / Mast Cell Activation
Inflammation Management
Respiratory Conditions
Skin Disorders
Suppressed Immune Function
Immune System Dysregulation
Neurological Disorders
Biotoxin Exposure
Mitochondrial Insufficiency
LDI is grounded in scientific evidence, restoring natural immune tolerance to specific environmental antigens. No significant adverse reactions were observed with over 10,000 patients in an initial US study from 1993-2001. Multiple double-blinded studies further underscore LDI's safety and efficacy. Notably, a US study revealed LDI's superiority in treating chronic ear infections, often linked to food reactions.